O	0	8	Patterns
O	9	11	of
O	12	21	adherence
O	22	24	to
B-Disease	25	33	diabetes
O	34	40	vision
O	41	45	care
O	46	56	guidelines
O	56	57	:
O	58	66	baseline
O	67	75	findings
O	76	80	from
O	81	84	the
B-Disease	85	93	Diabetic
I-Disease	94	105	Retinopathy
O	106	115	Awareness
O	116	123	Program
O	123	124	.

O	126	127	(
O	127	128	1
O	128	129	)
O	130	132	To
O	133	141	describe
O	142	150	baseline
O	151	159	patterns
O	160	162	of
O	163	172	adherence
O	173	175	to
O	176	184	American
B-Disease	185	193	Diabetes
O	194	205	Association
O	206	209	and
B-Classification_system	210	218	American
I-Classification_system	219	226	Academy
I-Classification_system	227	229	of
I-Classification_system	230	243	Ophthalmology
I-Classification_system	244	250	vision
I-Classification_system	251	255	care
I-Classification_system	256	266	guidelines
O	267	270	for
B-Disease	271	279	diabetes
O	280	282	in
O	283	286	the
B-Disease	287	295	Diabetic
I-Disease	296	307	Retinopathy
O	308	317	Awareness
O	318	325	Program
O	325	326	,
O	327	330	and
O	331	332	(
O	332	333	2
O	333	334	)
O	335	337	to
O	338	346	evaluate
O	347	354	factors
O	355	365	associated
O	366	370	with
O	371	383	nonadherence
O	383	384	.

O	385	389	This
O	390	395	paper
O	396	405	describes
O	406	409	the
O	410	418	baseline
O	419	434	characteristics
O	435	437	of
O	438	439	a
O	440	450	population
O	451	459	enrolled
O	460	462	in
O	463	464	a
O	465	476	prospective
O	476	477	,
O	478	488	randomized
O	489	497	clinical
O	498	503	trial
O	503	504	.

O	505	510	Cross
O	510	511	-
O	511	520	sectional
O	521	526	study
O	526	527	.

O	528	535	Between
O	536	543	October
O	544	548	1993
O	549	552	and
O	553	556	May
O	557	561	1994
O	561	562	,
O	563	566	the
O	567	572	study
O	573	583	identified
O	584	588	2308
O	589	596	persons
O	597	601	with
B-Disease	602	610	diabetes
O	610	611	,
B-Characteristic	612	614	18
I-Characteristic	615	620	years
I-Characteristic	621	623	of
I-Characteristic	624	627	age
I-Characteristic	628	630	or
I-Characteristic	631	636	older
O	636	637	,
O	638	641	who
O	642	646	were
B-Characteristic	647	656	residents
I-Characteristic	657	659	of
I-Characteristic	660	667	Suffolk
I-Characteristic	668	674	County
I-Characteristic	674	675	,
I-Characteristic	676	679	New
I-Characteristic	680	684	York
O	684	685	,
O	686	689	via
O	690	691	a
O	692	702	multimedia
O	703	712	community
O	712	713	-
O	713	717	wide
O	718	729	recruitment
O	730	738	campaign
O	738	739	.

O	740	751	Eligibility
O	752	755	for
O	756	759	the
O	760	765	trial
O	766	769	was
O	770	780	determined
O	781	787	during
O	788	789	a
O	790	792	20
O	792	793	-
O	793	799	minute
O	800	805	phone
O	806	815	interview
O	815	816	,
O	817	822	which
O	823	831	included
O	832	841	questions
O	842	847	about
O	848	854	vision
O	855	859	care
O	860	869	practices
O	869	870	;
B-Disease	871	879	diabetes
O	880	890	management
O	890	891	;
O	892	895	and
O	896	905	knowledge
O	905	906	,
O	907	916	attitudes
O	916	917	,
O	918	921	and
O	922	929	beliefs
O	930	935	about
B-Disease	936	944	diabetes
O	944	945	,
O	946	952	vision
O	952	953	,
O	954	957	and
B-Disease	958	966	diabetic
I-Disease	967	978	retinopathy
O	978	979	.

O	980	984	This
O	985	990	paper
O	991	1000	describes
O	1001	1006	these
O	1007	1014	patient
O	1015	1030	characteristics
O	1031	1033	at
O	1034	1042	baseline
O	1042	1043	.

O	1044	1052	Eligible
O	1053	1061	patients
O	1062	1067	would
O	1068	1070	be
O	1071	1081	randomized
O	1082	1094	subsequently
O	1095	1097	to
O	1098	1099	a
O	1100	1101	2
O	1101	1102	-
O	1102	1106	year
B-Disease	1107	1115	diabetes
O	1116	1127	educational
O	1128	1140	intervention
O	1141	1144	arm
O	1144	1145	,
O	1146	1151	which
O	1152	1160	included
O	1161	1167	mailed
O	1168	1175	packets
O	1176	1179	and
O	1180	1191	newsletters
O	1192	1199	focused
O	1200	1202	on
O	1203	1209	vision
O	1210	1214	care
O	1214	1215	,
O	1216	1218	or
O	1219	1221	to
O	1222	1223	a
O	1224	1231	control
O	1232	1247	nonintervention
O	1248	1251	arm
O	1251	1252	.

O	1253	1265	Nonadherence
O	1266	1268	to
O	1269	1279	guidelines
O	1280	1282	at
O	1283	1291	baseline
O	1292	1295	was
O	1296	1303	defined
O	1304	1306	as
O	1307	1310	the
O	1311	1318	absence
O	1319	1321	of
O	1322	1323	a
O	1324	1331	dilated
B-Anatomy	1332	1335	eye
O	1336	1347	examination
O	1348	1354	during
O	1355	1358	the
O	1359	1363	year
O	1364	1370	before
O	1371	1382	recruitment
O	1383	1387	into
O	1388	1391	the
O	1392	1397	study
O	1397	1398	.

O	1399	1401	Of
O	1402	1405	the
O	1406	1410	2308
O	1411	1418	persons
O	1419	1430	interviewed
O	1430	1431	,
O	1432	1435	813
O	1436	1437	(
O	1437	1439	35
O	1439	1440	%
O	1440	1441	)
O	1442	1445	did
O	1446	1449	not
O	1450	1456	follow
O	1457	1460	the
O	1461	1467	vision
O	1468	1472	care
O	1473	1483	guidelines
O	1483	1484	;
O	1485	1488	two
O	1489	1495	thirds
O	1496	1498	of
O	1499	1503	this
O	1504	1509	group
O	1510	1518	reported
O	1519	1521	no
B-Anatomy	1522	1525	eye
O	1526	1537	examination
O	1538	1540	in
O	1541	1544	the
O	1545	1549	year
O	1550	1556	before
O	1557	1560	the
O	1561	1570	interview
O	1570	1571	,
O	1572	1575	and
O	1576	1579	one
O	1580	1585	third
O	1586	1589	had
O	1590	1592	an
O	1593	1602	undilated
O	1603	1614	examination
O	1614	1615	.

O	1616	1632	Ophthalmologists
O	1633	1642	performed
O	1643	1645	49
O	1645	1646	%
O	1647	1649	of
O	1650	1653	the
O	1654	1666	examinations
O	1667	1669	in
O	1670	1673	the
O	1674	1685	nonadherent
O	1686	1691	group
O	1691	1692	,
O	1693	1699	versus
O	1700	1702	86
O	1702	1703	%
O	1704	1706	in
O	1707	1710	the
O	1711	1719	adherent
O	1720	1725	group
O	1725	1726	.

O	1727	1729	In
O	1730	1738	logistic
O	1739	1749	regression
O	1750	1758	analyses
O	1758	1759	,
O	1760	1767	factors
O	1768	1775	related
O	1776	1778	to
O	1779	1791	nonadherence
O	1792	1796	were
O	1796	1797	:
B-Characteristic	1798	1805	younger
I-Characteristic	1806	1809	age
O	1810	1811	(
O	1811	1815	odds
O	1816	1821	ratio
O	1822	1823	[
O	1823	1825	OR
O	1825	1826	]
O	1827	1828	=
O	1829	1830	0
O	1830	1831	.
O	1831	1833	97
O	1833	1834	)
O	1834	1835	,
B-Disease	1836	1840	type
I-Disease	1841	1842	2
I-Disease	1843	1851	diabetes
O	1852	1856	with
O	1857	1859	or
O	1860	1867	without
O	1868	1875	insulin
O	1876	1879	use
O	1880	1881	(
O	1881	1883	OR
O	1884	1885	=
O	1886	1887	1
O	1887	1888	.
O	1888	1890	62
O	1891	1894	and
O	1895	1896	1
O	1896	1897	.
O	1897	1899	99
O	1899	1900	,
O	1901	1913	respectively
O	1913	1914	)
O	1914	1915	,
O	1916	1923	shorter
B-Characteristic	1924	1932	diabetes
I-Characteristic	1933	1941	duration
O	1942	1943	(
O	1943	1945	OR
O	1946	1947	=
O	1948	1949	0
O	1949	1950	.
O	1950	1952	97
O	1952	1953	)
O	1953	1954	,
O	1955	1959	last
B-Characteristic	1960	1963	eye
I-Characteristic	1964	1975	examination
I-Characteristic	1976	1985	performed
I-Characteristic	1986	1988	by
I-Characteristic	1989	1991	an
I-Characteristic	1992	2003	optometrist
O	2004	2005	(
O	2005	2007	OR
O	2008	2009	=
O	2010	2011	5
O	2011	2012	.
O	2012	2014	32
O	2014	2015	)
O	2016	2018	or
O	2019	2024	other
O	2025	2043	nonophthalmologist
O	2044	2045	(
O	2045	2047	OR
O	2048	2049	=
O	2050	2051	4
O	2051	2052	.
O	2052	2054	29
O	2054	2055	)
O	2055	2056	,
O	2057	2061	less
B-Characteristic	2062	2071	practical
I-Characteristic	2072	2081	knowledge
I-Characteristic	2082	2087	about
I-Characteristic	2088	2096	diabetes
O	2097	2098	(
O	2098	2100	OR
O	2101	2102	=
O	2103	2104	1
O	2104	2105	.
O	2105	2107	57
O	2107	2108	)
O	2108	2109	,
O	2110	2113	and
O	2114	2116	no
B-Characteristic	2117	2122	prior
I-Characteristic	2123	2129	formal
I-Characteristic	2130	2138	diabetes
I-Characteristic	2139	2148	education
O	2149	2150	(
O	2150	2152	OR
O	2153	2154	=
O	2155	2156	1
O	2156	2157	.
O	2157	2159	30
O	2159	2160	)
O	2160	2161	.

O	2162	2168	Within
O	2169	2173	this
O	2174	2184	population
O	2184	2185	,
O	2186	2190	more
O	2191	2195	than
O	2196	2199	one
O	2200	2205	third
O	2206	2208	of
O	2209	2221	participants
O	2222	2225	had
O	2226	2229	not
O	2230	2234	been
O	2235	2244	following
O	2245	2251	vision
O	2252	2256	care
O	2257	2267	guidelines
O	2267	2268	.

O	2269	2281	Nonadherence
O	2282	2285	was
O	2286	2292	linked
O	2293	2295	to
O	2296	2303	several
O	2304	2315	potentially
O	2316	2326	modifiable
O	2327	2334	factors
O	2334	2335	;
O	2336	2343	changes
O	2344	2346	in
O	2347	2352	these
O	2353	2360	factors
O	2361	2366	could
O	2367	2374	enhance
O	2375	2378	the
O	2379	2384	early
O	2385	2394	detection
O	2395	2397	of
B-Disease	2398	2406	diabetic
I-Disease	2407	2418	retinopathy
O	2418	2419	.
